Regeneron (REGN) volatility flat into JPMorgan 35rh Annual Healthcare Conference

Go back to Regeneron (REGN) volatility flat into JPMorgan 35rh Annual Healthcare Conference

Jefferies Cuts Price Target on Regeneron (REGN) Following District Court Ruling

January 6, 2017 9:28 AM EST

Jefferies maintained a Hold rating on Regeneron Pharma (NASDAQ: REGN), and cut the price target to $349.00 (from $394.00), following a decision by the District Court of Delaware. Judge Sue Robinson at the District Court of Delaware ruled in favor of Amgen (NASDAQ:... More

Regeneron (REGN) Falls 8% as Trading Resumes

January 6, 2017 7:12 AM EST

Regeneron (NASDAQ: REGN) is down 7.9% as trading resumes.

... More